The cell biology of thrombospondin-1.

[1]  A. Ludlow,et al.  Activation of Platelet-transforming Growth Factor β-1 in the Absence of Thrombospondin-1* , 2000, The Journal of Biological Chemistry.

[2]  J. Murphy-Ullrich,et al.  Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology , 2000 .

[3]  H. Fillit,et al.  Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1. , 2000, Archives of biochemistry and biophysics.

[4]  O. Volpert,et al.  Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 , 2000, Nature Medicine.

[5]  F. Matsumura,et al.  Cell-matrix adhesions differentially regulate fascin phosphorylation. , 1999, Molecular biology of the cell.

[6]  T. Shono,et al.  Role of thrombospondin-1-derived peptide, 4N1K, in FGF-2-induced angiogenesis. , 1999, Experimental cell research.

[7]  L. Lagneaux,et al.  CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia , 1999, Nature Medicine.

[8]  M. Armant,et al.  Cd47 Ligation Selectively Downregulates Human Interleukin 12 Production , 1999, The Journal of experimental medicine.

[9]  F. Lindberg,et al.  Integrin-Associated Protein Stimulates α2β1-Dependent Chemotaxis via GI-Mediated Inhibition of Adenylate Cyclase and Extracellular-Regulated Kinases , 1999, The Journal of cell biology.

[10]  K. Gardner,et al.  Beta 1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides. , 1999, Journal of immunology.

[11]  M. Iruela-Arispe,et al.  Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. , 1999, Circulation.

[12]  L. Miller,et al.  CD36 peptides that block cytoadherence define the CD36 binding region for Plasmodium falciparum-infected erythrocytes. , 1999, Blood.

[13]  S. Mai,et al.  Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. , 1999, The American journal of pathology.

[14]  A. Hughes,et al.  Phosphatidylinositol 3-kinase and focal adhesion kinase are early signals in the growth factor-like responses to thrombospondin-1 seen in human vascular smooth muscle. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[15]  F. Lindberg,et al.  Impaired memory retention and decreased long-term potentiation in integrin-associated protein-deficient mice. , 1999, Learning & memory.

[16]  H. Krutzsch,et al.  Identification of an α3β1 Integrin Recognition Sequence in Thrombospondin-1* , 1999, The Journal of Biological Chemistry.

[17]  M. Iruela-Arispe,et al.  METH-1, a Human Ortholog of ADAMTS-1, and METH-2 Are Members of a New Family of Proteins with Angio-inhibitory Activity* , 1999, The Journal of Biological Chemistry.

[18]  H. Krutzsch,et al.  Cooperation between Thrombospondin-1 Type 1 Repeat Peptides and αvβ3 Integrin Ligands to Promote Melanoma Cell Spreading and Focal Adhesion Kinase Phosphorylation* , 1999, The Journal of Biological Chemistry.

[19]  M. Skobe,et al.  Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. , 1999, The American journal of pathology.

[20]  V. Gahtan,et al.  Thrombospondin-1 regulation of smooth muscle cell chemotaxis is extracellular signal-regulated protein kinases 1/2 dependent. , 1999, Surgery.

[21]  F. Lindberg,et al.  Thrombospondin-1 Acts Via IAP/CD47 to Synergize With Collagen in 2β1-Mediated Platelet Activation , 1999 .

[22]  V. Gahtan,et al.  Thrombospondin-1 induces activation of focal adhesion kinase in vascular smooth muscle cells. , 1999, Journal of vascular surgery.

[23]  S. Schultz-Cherry,et al.  The Activation Sequence of Thrombospondin-1 Interacts with the Latency-associated Peptide to Regulate Activation of Latent Transforming Growth Factor-β* , 1999, The Journal of Biological Chemistry.

[24]  D. Roberts,et al.  Pro-adhesive and Chemotactic Activities of Thrombospondin-1 for Breast Carcinoma Cells Are Mediated by α3β1 Integrin and Regulated by Insulin-like Growth Factor-1 and CD98* , 1999, The Journal of Biological Chemistry.

[25]  E. Brown,et al.  The Thrombospondin Receptor Integrin-associated Protein (CD47) Functionally Couples to Heterotrimeric Gi * , 1999, The Journal of Biological Chemistry.

[26]  N. Fusenig,et al.  Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  F. Lindberg,et al.  The Vitronectin Receptor and its Associated CD47 Molecule Mediates Proinflammatory Cytokine Synthesis in Human Monocytes by Interaction with Soluble CD23 , 1999, The Journal of cell biology.

[28]  O. Volpert,et al.  Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat. , 1999, Molecular pharmacology.

[29]  D. Mosher,et al.  Interaction of Recombinant Procollagen and Properdin Modules of Thrombospondin-1 with Heparin and Fibrinogen/Fibrin* , 1999, The Journal of Biological Chemistry.

[30]  F. Lindberg,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Thrombospondin-1 Acts Via IAP/CD47 to Synergize With Collagen in a2b1-Mediated Platelet Activation , 1999 .

[31]  N. Bouck,et al.  Thrombospondin as an Inhibitor of Angiogenesis , 1999 .

[32]  A. Lander,et al.  Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: assessment of selectivity, heterogeneity and the participation of core proteins in binding. , 1999, Glycobiology.

[33]  B. Teicher.  Antiangiogenic agents in cancer therapy , 1998 .

[34]  P. Hogg,et al.  Exposure of the cryptic Arg-Gly-Asp sequence in thrombospondin-1 by protein disulfide isomerase. , 1998, Biochimica et biophysica acta.

[35]  Y. Fukushima,et al.  Alterations in tumour suppressor gene p53 correlate with inhibition of thrombospondin-1 gene expression in colon cancer cells , 1998, Virchows Archiv.

[36]  M. Hemler.  Integrin associated proteins. , 1998, Current opinion in cell biology.

[37]  N. Hogg,et al.  Integrins take partners: cross-talk between integrins and other membrane receptors. , 1998, Trends in cell biology.

[38]  D. Clemmons,et al.  Blocking ligand occupancy of the αVβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells , 1998 .

[39]  Josephine C. Adams,et al.  Muskelin, a novel intracellular mediator of cell adhesive and cytoskeletal responses to thrombospondin‐1 , 1998, The EMBO journal.

[40]  R. Hynes,et al.  Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo , 1998, Cell.

[41]  A‐Min Huang,et al.  Expression of Integrin-Associated Protein Gene Associated with Memory Formation in Rats , 1998, The Journal of Neuroscience.

[42]  Xue-qing Wang,et al.  The Thrombospondin Receptor CD47 (IAP) Modulates and Associates with α2β1 Integrin in Vascular Smooth Muscle Cells , 1998 .

[43]  S. Campbell,et al.  Molecular mediators of angiogenesis in bladder cancer. , 1998, Cancer research.

[44]  J. Isner,et al.  Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries. , 1998, American heart journal.

[45]  J. Enenstein,et al.  Thrombin-stimulated calcium mobilization is inhibited by thrombospondin via CD36. , 1998, Experimental cell research.

[46]  A. Theibert,et al.  Thrombospondin Signaling of Focal Adhesion Disassembly Requires Activation of Phosphoinositide 3-Kinase* , 1998, The Journal of Biological Chemistry.

[47]  R. Silverstein,et al.  Identification of a CD36-related Thrombospondin 1–binding Domain in HIV-1 Envelope Glycoprotein gp120: Relationship to HIV-1–specific Inhibitory Factors in Human Saliva , 1998, The Journal of experimental medicine.

[48]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[49]  H. Krutzsch,et al.  Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[50]  J. Adams,et al.  Characterization of cell-matrix adhesion requirements for the formation of fascin microspikes. , 1997, Molecular biology of the cell.

[51]  A. Hughes,et al.  Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[52]  P. Delmas,et al.  Decorin inhibits cell attachment to thrombospondin‐1 by binding to a KKTR‐dependent cell adhesive site present within the N‐terminal domain of thrombospondin‐1 , 1997, Journal of cellular biochemistry.

[53]  Yusuke Nakamura,et al.  A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis , 1997, Oncogene.

[54]  David W. Dawson,et al.  CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells , 1997, The Journal of cell biology.

[55]  L. Daviet,et al.  Thrombospondin Induces Dimerization of Membrane-Bound, but not Soluble CD36 , 1997, Thrombosis and Haemostasis.

[56]  J. Esko,et al.  Cell Adhesion to a Motif Shared by the Malaria Circumsporozoite Protein and Thrombospondin Is Mediated by Its Glycosaminoglycan-binding Region and Not by CSVTCG* , 1997, The Journal of Biological Chemistry.

[57]  P. Schön,et al.  Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells. , 1997, European journal of cell biology.

[58]  L. Daviet,et al.  Vascular Biology of CD36: Roles of this New Adhesion Molecule Family in Different Disease States , 1997, Thrombosis and Haemostasis.

[59]  J. Chung,et al.  Thrombspondin Acts via Integrin-associated Protein to Activate the Platelet Integrin αIIbβ3 * , 1997, The Journal of Biological Chemistry.

[60]  T. Suda,et al.  Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36‐anchored Lyn tyrosine kinase in thrombin‐stimulated platelets , 1997, The EMBO journal.

[61]  D. Rifkin,et al.  Latent transforming growth factor-beta: structural features and mechanisms of activation. , 1997, Kidney international.

[62]  K. Dameron,et al.  Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity , 1997, Oncogene.

[63]  A. Sieron,et al.  cDNA cloning and expression of bovine procollagen I N-proteinase: a new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[64]  S. Groshen,et al.  Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. , 1997, Journal of the National Cancer Institute.

[65]  M. Shakibaei,et al.  The malaria circumsporozoite protein: interaction of the conserved regions I and II-plus with heparin-like oligosaccharides in heparan sulfate. , 1997, Experimental parasitology.

[66]  M. Lovett,et al.  Isolation of cDNAs from the Cri-du-chat critical region by direct screening of a chromosome 5-specific cDNA library. , 1997, Genome research.

[67]  J. Gnarra,et al.  Identification of an Actin Binding Region and a Protein Kinase C Phosphorylation Site on Human Fascin* , 1997, The Journal of Biological Chemistry.

[68]  K. Matsushima,et al.  Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated Gene* , 1997, The Journal of Biological Chemistry.

[69]  Eric J. Brown,et al.  Decreased Resistance to Bacterial Infection and Granulocyte Defects in IAP-Deficient Mice , 1996, Science.

[70]  B. Vargaftig,et al.  Evidence for cAMP-dependent Platelet Ectoprotein Kinase Activity That Phosphorylates Platelet Glycoprotein IV (CD36)* , 1996, The Journal of Biological Chemistry.

[71]  D. Strickland,et al.  Binding and degradation of thrombospondin-1 mediated through heparan sulphate proteoglycans and low-density-lipoprotein receptor-related protein: localization of the functional activity to the trimeric N-terminal heparin-binding region of thrombospondin-1. , 1996, The Biochemical journal.

[72]  D. Lublin,et al.  CD36 Is Palmitoylated on Both N- and C-terminal Cytoplasmic Tails* , 1996, The Journal of Biological Chemistry.

[73]  C. Haslett,et al.  Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response. , 1996, The American journal of pathology.

[74]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[75]  D. Roberts,et al.  Regulation of tumor growth and metastasis by thrombospondin‐1 , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[76]  D. D. Shock,et al.  Glycoprotein IV-independent adhesion of sickle red blood cells to immobilized thrombospondin under flow conditions. , 1996, Blood.

[77]  J. Scott,et al.  Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin. , 1996, Blood.

[78]  R. Adams,et al.  A novel class of murine semaphorins with homology to thrombospondin is differentially expressed during early embryogenesis , 1996, Mechanisms of Development.

[79]  F. Matsumura,et al.  Phosphorylation of Human Fascin Inhibits Its Actin Binding and Bundling Activities (*) , 1996, The Journal of Biological Chemistry.

[80]  B. Dastugue,et al.  SCO-spondin: a new member of the thrombospondin family secreted by the subcommissural organ is a candidate in the modulation of neuronal aggregation. , 1996, Journal of cell science.

[81]  H. van den Berghe,et al.  Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican , 1996, The Journal of cell biology.

[82]  S. Colgan,et al.  CD47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia , 1996, The Journal of cell biology.

[83]  E. Brown,et al.  Integrin-associated Protein Is a Receptor for the C-terminal Domain of Thrombospondin (*) , 1996, The Journal of Biological Chemistry.

[84]  M. Yin,et al.  Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[85]  Josephine C. Adams,et al.  The Thrombospondin Gene Family , 1995 .

[86]  D. Mendrick,et al.  Identification of integrin α 3 β 1 as a neuronal thrombospondin receptor mediating neurite outgrowth , 1995, Neuron.

[87]  S. Stefansson,et al.  Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1 , 1995, The Journal of cell biology.

[88]  J. Adams,et al.  Formation of stable microspikes containing actin and the 55 kDa actin bundling protein, fascin, is a consequence of cell adhesion to thrombospondin-1: implications for the anti-adhesive activities of thrombospondin-1. , 1995, Journal of cell science.

[89]  R. Silverstein,et al.  CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis , 1995, The Journal of experimental medicine.

[90]  J. Gamble,et al.  Transendothelial migration of neutrophils involves integrin-associated protein (CD47). , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[91]  I. Mikhailenko,et al.  Low Density Lipoprotein Receptor-related Protein/-Macroglobulin Receptor Mediates the Cellular Internalization and Degradation of Thrombospondin , 1995, The Journal of Biological Chemistry.

[92]  H. Krutzsch,et al.  Regulation of Transforming Growth Factor-β Activation by Discrete Sequences of Thrombospondin 1 (*) , 1995, The Journal of Biological Chemistry.

[93]  D. Mosher,et al.  Calcium Ion Binding to Thrombospondin 1 (*) , 1995, The Journal of Biological Chemistry.

[94]  G. Boivin,et al.  Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice. , 1995, The American journal of pathology.

[95]  V. Dixit,et al.  Properties of recombinant mouse thrombospondin 2 expressed in Spodoptera cells. , 1994, The Journal of biological chemistry.

[96]  A. Yayon,et al.  Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis , 1994, Cell.

[97]  P. Steeg,et al.  Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. , 1994, Cancer research.

[98]  W. Frazier,et al.  Identification of a receptor candidate for the carboxyl-terminal cell binding domain of thrombospondins. , 1994, The Journal of biological chemistry.

[99]  S. Wahl,et al.  Transforming growth factor beta: the good, the bad, and the ugly , 1994, The Journal of experimental medicine.

[100]  S. Schultz-Cherry,et al.  Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. , 1994, The Journal of biological chemistry.

[101]  K. Dameron,et al.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.

[102]  P. Brickell,et al.  src‐related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells , 1994, FEBS letters.

[103]  J. Wu,et al.  Thrombospondin: Evidence for a Single Transmembrane Domain a Carboxyl Terminal Truncation Mutant of Cd36 Is Secreted and Binds , 2022 .

[104]  M. Lyon,et al.  Liver heparan sulfate structure. A novel molecular design. , 1994, The Journal of biological chemistry.

[105]  J. Lawler,et al.  Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1. , 1994, Molecular biology of the cell.

[106]  V. Nussenzweig,et al.  Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes , 1994, The Journal of experimental medicine.

[107]  A. Yayon,et al.  Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. , 1994, The Journal of biological chemistry.

[108]  M. Höök,et al.  Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity. , 1993, The Journal of biological chemistry.

[109]  J. Barnwell,et al.  Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain. , 1993, Science.

[110]  E. Schwarz,et al.  Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding , 1993, The Journal of cell biology.

[111]  U. Ryan,et al.  Thrombospondin mediates migration and potentiates platelet‐derived growth factor‐dependent migration of calf pulmonary artery smooth muscle cells , 1993, Journal of cellular physiology.

[112]  P. Polverini,et al.  Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1. , 1993, The American journal of pathology.

[113]  H. Krutzsch,et al.  Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin‐binding domain and synthetic peptides from the type I repeats of thrombospondin , 1993, Journal of cellular biochemistry.

[114]  S. Schultz-Cherry,et al.  Thrombospondin causes activation of latent transforming growth factor- beta secreted by endothelial cells by a novel mechanism [published erratum appears in J Cell Biol 1993 Sep;122(5):following 1143] , 1993, Journal of Cell Biology.

[115]  O. Volpert,et al.  Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity , 1993, The Journal of cell biology.

[116]  V. Dixit,et al.  Activated T-cell adhesion to thrombospondin is mediated by the alpha 4 beta 1 (VLA-4) and alpha 5 beta 1 (VLA-5) integrins. , 1993, Journal of immunology.

[117]  V. Nussenzweig,et al.  Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes , 1993, The Journal of experimental medicine.

[118]  W. Frazier,et al.  Identification of a new cell adhesion motif in two homologous peptides from the COOH-terminal cell binding domain of human thrombospondin. , 1993, The Journal of biological chemistry.

[119]  J. Lawler,et al.  Diverse mechanisms for cell attachment to platelet thrombospondin. , 1993, Journal of cell science.

[120]  G. Tuszynski,et al.  Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain , 1993, The Journal of cell biology.

[121]  P. Schön,et al.  Cell-associated proteoheparan sulfate mediates binding and uptake of thrombospondin in cultured porcine vascular endothelial cells. , 1992, European journal of cell biology.

[122]  P. Bornstein,et al.  Thrombospondins: structure and regulation of expression , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[123]  J. Culotti,et al.  UNC-5, a transmembrane protein with immunoglobulin and thrombospondin type 1 domains, guides cell and pioneer axon migrations in C. elegans , 1992, Cell.

[124]  H. Kresse,et al.  Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment. , 1992, European journal of cell biology.

[125]  J Savill,et al.  Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. , 1992, The Journal of clinical investigation.

[126]  H. Krutzsch,et al.  Heparin-binding peptides from the type I repeats of thrombospondin. Structural requirements for heparin binding and promotion of melanoma cell adhesion and chemotaxis. , 1992, The Journal of biological chemistry.

[127]  L. Leung,et al.  CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction. , 1992, The Journal of biological chemistry.

[128]  H. Ikeda,et al.  Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. , 1992, Blood.

[129]  R. Silverstein,et al.  Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor. , 1992, The Journal of biological chemistry.

[130]  W. Frazier,et al.  Identification of active peptide sequences in the carboxyl-terminal cell binding domain of human thrombospondin-1. , 1992, The Journal of biological chemistry.

[131]  K. Skorstengaard,et al.  Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin , 1992, The Journal of cell biology.

[132]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[133]  T. Jessell,et al.  F-spondin: A gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension , 1992, Cell.

[134]  H. Krutzsch,et al.  Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[135]  R. Nachman,et al.  Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. , 1992, Biochemical and biophysical research communications.

[136]  S. Schultz-Cherry,et al.  Transforming growth factor-beta complexes with thrombospondin. , 1992, Molecular biology of the cell.

[137]  W. Frazier,et al.  Cell attachment activity of the carboxyl-terminal domain of human thrombospondin expressed in Escherichia coli. , 1991, The Journal of biological chemistry.

[138]  J. Brugge,et al.  Protein tyrosine phosphorylation and the adhesive functions of platelets. , 1991, Current opinion in cell biology.

[139]  J. Barnwell,et al.  Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[140]  L. Gentry,et al.  Identification and analysis of discrete functional domains in the pro region of pre-pro-transforming growth factor beta 1 , 1991, The Journal of cell biology.

[141]  V. Dixit,et al.  Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor. , 1991, Cancer research.

[142]  L. Reichardt,et al.  Vitronectin and thrombospondin promote retinal neurite outgrowth: Developmental regulation and role of integrins , 1991, Neuron.

[143]  Gressner Am.  Beta-D-xyloside induced modulations of glycosaminoglycans, proliferation, and cytoskeletal organization of rat liver myofibroblast-like cells (transformed fat storing cells). , 1991 .

[144]  M. L. Le Beau,et al.  A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[145]  M. Mayberg,et al.  Thrombospondin deposition in rat carotid artery injury. , 1990, The American journal of pathology.

[146]  M. Pangburn,et al.  Properdin binds to sulfatide [Gal(3-SO4)beta 1-1 Cer] and has a sequence homology with other proteins that bind sulfated glycoconjugates. , 1990, The Journal of biological chemistry.

[147]  D. Mosher.  Physiology of thrombospondin. , 1990, Annual review of medicine.

[148]  G. Tuszynski,et al.  The interaction of thrombospondin with platelet glycoprotein GPIIb-IIIa. , 1989, The Journal of biological chemistry.

[149]  R. Hynes,et al.  An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin [see comments] , 1989 .

[150]  R. Silverstein,et al.  Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. , 1989, The Journal of clinical investigation.

[151]  Brian Seed,et al.  CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes , 1989, Cell.

[152]  D. Roberts.  Interactions of thrombospondin with sulfated glycolipids and proteoglycans of human melanoma cells. , 1988, Cancer research.

[153]  R. Hynes,et al.  Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors , 1988, The Journal of cell biology.

[154]  V. Dixit,et al.  Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation , 1988, The Journal of cell biology.

[155]  D. Roberts,et al.  Platelet thrombospondin mediates attachment and spreading of human melanoma cells , 1987, The Journal of cell biology.

[156]  P. Bornstein,et al.  Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[157]  J. Connolly,et al.  Thrombin and Chymotrypsin Interactions with Thrombospondin a , 1986, Annals of the New York Academy of Sciences.

[158]  L. Liotta,et al.  Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipids. , 1986, The Journal of biological chemistry.

[159]  V. Dixit,et al.  Monoclonal antibodies that recognize calcium-dependent structures of human thrombospondin. Characterization and mapping of their epitopes. , 1986, The Journal of biological chemistry.

[160]  V. Dixit,et al.  Mapping of epitopes for monoclonal antibodies against human platelet thrombospondin with electron microscopy and high sensitivity amino acid sequencing , 1985, The Journal of cell biology.

[161]  V. Dixit,et al.  The platelet glycoprotein thrombospondin binds specifically to sulfated glycolipids. , 1985, The Journal of biological chemistry.

[162]  V. Dixit,et al.  A monoclonal antibody against human thrombospondin inhibits platelet aggregation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[163]  L. Leung,et al.  Role of thrombospondin in platelet aggregation. , 1984, The Journal of clinical investigation.

[164]  P. McKeown-Longo,et al.  Binding and degradation of platelet thrombospondin by cultured fibroblasts , 1984, The Journal of cell biology.

[165]  J. Lawler,et al.  Cooperative binding of calcium to thrombospondin. The effect of calcium on the circular dichroism and limited tryptic digestion of thrombospondin. , 1983, The Journal of biological chemistry.

[166]  S. Singer,et al.  The Fluid Mosaic Model of the Structure of Cell Membranes , 1972, Science.